Concepedia

Joshua Chen

JC

17

Publications

1.8K

Citations

15

H-Index

2002

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Sanofi (United States)

Novartis (United States)

Bristol-Myers Squibb (Switzerland)

Johnson & Johnson (United States)

Joshua Chen is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, health sciences, and clinical trial design.

ORCID

Top concepts

Publications per year

2002–2020

17

Publications

17

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Roy T. Steigbigel, David A. Cooper, Princy Kumar et al. · New England Journal of Medicine · 2008 · 683 citations · Full text

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

David A. Cooper, Roy T. Steigbigel, José M. Gatell et al. · New England Journal of Medicine · 2008 · 505 citations · Full text

TikTok and Its Role in COVID-19 Information Propagation

Adam M. Ostrovsky, Joshua Chen · Journal of Adolescent Health · 2020 · 122 citations · Full text

, , +4

Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression

David Sant, Sushmita Mustafi, Christopher B. Gustafson et al. · Scientific Reports · 2018 · 83 citations · Full text

Lack of a Significant Drug Interaction between Raltegravir and Tenofovir

Larissa Wenning, Evan Friedman, James Kost et al. · Antimicrobial Agents and Chemotherapy · 2008 · 72 citations · Full text

Rows per page

1–5 of 17